Mode of Action, Clinical Profile and Significance of Beta-Blockers in Antiglaucoma Therapy

被引：3
|
作者：
Schlote, T. [1 ]
机构：
[1] Tagesklin Ambimed, CH-4057 Basel, Switzerland
来源：
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE | 2013年 / 230卷 / 02期
关键词：
glaucoma; pharmacology; biochemistry; DIURNAL INTRAOCULAR-PRESSURE; TIMOLOL MALEATE; UNFIXED COMBINATION; FIXED COMBINATION; GLAUCOMA PATIENTS; EFFICACY; TOLERABILITY; METAANALYSIS; EXFOLIATION; SAFETY;
D O I：
10.1055/s-0032-1327784
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Beta-blockers are among the most important groups of drugs for glaucoma therapy. The advantages of beta-blockers are a good efficacy in primary and secondary types of glaucoma, different dosages, clinical experiences over decades, easy use in combination with all other glaucoma drugs, and low costs. Timolol is the most frequently used drug in fixed glaucoma medications. In comparison with other glaucoma drugs, beta-blockers have the most severe systemic side effects and may interact with other systemic medication.
引用
收藏
页码：120 / 126
页数：7
相关论文
共 50 条
  • [41] Response to: A myth of ophthalmic beta-blockers therapy
    Wolfs, Roger C. W.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (12) : 1723 - 1723
  • [42] RECURRENT HYPOGLYCEMIA IN TODDLER WITH BETA-BLOCKERS THERAPY
    Pepin, Veronique
    Gagne, Nancy
    Rottembourg, Diane
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 107 - 107
  • [43] BETA-BLOCKERS AND NITRITES IN ANGINA PECTORIS THERAPY
    HAARMANN, K
    NEFF, K
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1974, 63 (12): : 355 - &
  • [44] Trial watch: beta-blockers in cancer therapy
    Le Provost, Killian Carnet
    Kepp, Oliver
    Kroemer, Guido
    Bezu, Lucillia
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [45] BETA-BLOCKERS AS ADJUVANT THERAPY IN DELIRIUM TREMENS
    HOLZBACH, E
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1980, 122 (22): : 837 - 840
  • [46] Beta-blockers: Essential heart failure therapy
    Ginsberg, Fredric
    CRITICAL CARE MEDICINE, 2011, 39 (05) : 1198 - 1199
  • [47] Beta-blockers in heart failure - a cardioprotective therapy?
    Landray, MJ
    Kendall, MJ
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1997, 22 (03) : 181 - 185
  • [48] Clinical effects of beta-blockers on portal hypertension
    Kuga, K
    Onoda, Y
    Tanaka, S
    Komaba, M
    Kamoshita, H
    Toshima, K
    Uematu, M
    Imai, F
    Toda, G
    HEPATOLOGY, 1996, 23 (01) : P151 - P151
  • [49] THE CLINICAL INTERACTION BETWEEN LIDOCAINE AND BETA-BLOCKERS
    WYSE, DG
    KELLEN, J
    TAM, Y
    RADEMAKER, A
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : B56 - B56
  • [50] Cushing syndrome with clinical response to beta-blockers
    Arnez, Lorena
    Portela, Marina
    Biagetti, Betina
    Mesa, Jordi
    MEDICINA CLINICA, 2012, 139 (09): : 413 - 414
12345